This is when a person develops a new cancer or tumor after having had one before. It's not the original cancer spreading (that's called metastasis). The new cancer might be the same type or a different type, and it can happen in the same or a different part of the body. It often happens because of factors like genetics or previous treatments.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
A second primary tumor, often called a second cancer, is a new cancer that develops in someone who has had cancer before. It starts on its own rather than growing from the first cancer. That makes it different from a recurrence, when the original cancer comes back, and from metastasis, when the original cancer spreads to another part of the body. A second cancer can appear in the same organ as the first, such as a different type of colorectal cancer after an earlier one, or somewhere else entirely, such as lung cancer years after breast cancer. The distinction matters because a new cancer is treated as the disease it is, which can differ greatly from how a returning first cancer would be treated. Second cancers are not common, but they have become more frequent as more people survive cancer and live for decades afterward. How likely one is depends mainly on the first cancer, the treatment it required and the age at which it was diagnosed.
Often no single cause can be identified. The same things that raised the risk of a first cancer can raise the risk of another, and age itself plays a part, since cancer becomes more common as people get older. Shared exposures are a large part of the picture. Smoking is linked to cancers of the lung, mouth, voice box, bladder and pancreas, so someone treated for one of them faces a higher chance of another. Cancers associated with smoking or excess weight account for a substantial share of second cancers in adults, and lung cancer is the most common cause of death from a second cancer. Alcohol, sun exposure and certain infections, such as human papillomavirus (HPV), also contribute. Some cancer treatments carry a long-term risk of their own. Radiation can damage the DNA of healthy cells near the treated area, and the solid tumors it causes, such as breast, thyroid or lung cancer or a sarcoma (a cancer of bone or soft tissue), usually appear 10 years or more later, in or near the treated field. The risk is greater at higher doses and in people treated as children or young adults. Some chemotherapy drugs, particularly alkylating agents (such as cyclophosphamide) and anthracyclines (such as doxorubicin), can lead to blood cancers such as acute myeloid leukemia, usually within about 10 years. Tamoxifen, a hormone therapy for breast cancer, slightly raises the chance of uterine cancer. Newer targeted drugs and immunotherapies have been used for a shorter time, so less is known about their long-term effects. Inherited gene changes are another route. Conditions such as hereditary breast and ovarian cancer syndrome (most often from BRCA1 or BRCA2 changes) and Lynch syndrome raise the risk of several kinds of cancer over a lifetime. Inherited factors appear to play an especially large role in second cancers among people who had cancer as children.
A second cancer may be found because of new symptoms, through routine screening such as a mammogram or colonoscopy, or on a scan done to monitor the first cancer. The key question is whether a new growth is a separate cancer or the original one returning or spreading, and imaging alone often cannot answer it. A biopsy, in which a small sample of tissue is removed and examined, is usually needed when treatment is being considered. The pathologist compares the new sample with tissue from the first cancer, looking at what kind of cell each began in and how the cells look and behave. Making sure the pathologist knows about the earlier diagnosis and has the original tissue available makes that comparison more reliable. When someone has had several cancers, has had cancer at a young age, or has close relatives with related cancers, the care team may recommend genetic counseling and testing. A positive result can change screening plans for the person and for their family.
A second cancer is treated according to its own type and stage, so the options are those for that cancer: surgery, radiation, chemotherapy, hormone therapy, targeted drugs or immunotherapy, alone or in combination. Depending on its type and stage, a second cancer may still be treated with the aim of cure. What makes planning different is the treatment a person has already had. An area that received radiation before may not safely tolerate a full second course. Some chemotherapy drugs, such as anthracyclines, can only be given up to a certain total dose over a lifetime. Earlier surgery can limit what operations remain possible, and lasting side effects such as nerve damage or low blood counts can affect which drugs are tolerable. If the first cancer is still active, the team has to decide which cancer poses the greater threat and whether one regimen can treat both. Because these decisions are often complex, they are usually made by a team that includes specialists for both cancers. Stopping smoking and addressing other ongoing risks remains worthwhile at this stage too.
The outlook depends on the type and stage of the second cancer, the person's overall health, and how much the first treatment limits the options. A second cancer found early, before it has spread, is generally easier to treat, while one found late, or one that appears while the first cancer is still active, is harder to treat. Registry studies show that survivors of many cancers have a higher risk of dying from a second cancer than people of the same age without a prior cancer, which is why ongoing follow-up matters. For people who have finished treatment, long-term follow-up is the main safeguard. A treatment summary and survivorship care plan list what was given, which screening tests are needed and when, and which doctor is responsible for ordering them. Screening may start earlier or happen more often than usual: for example, women who had high-dose chest radiation when young are typically offered yearly breast imaging beginning at age 25 or 8 years after treatment, whichever is later. Many survivors also follow the ordinary screening schedule for their age. Living with this risk can be stressful, especially for people who once thought cancer was behind them. Not smoking, limiting alcohol, staying active, protecting skin from the sun and keeping a healthy weight can help lower the chance of another cancer, and they also support heart and general health after treatment.
If you have had cancer and do not have a clear survivorship care plan, ask your oncology team or primary care clinician for one, including which screening tests you need and who will order them. Consider a genetics referral if you have had more than one cancer, had cancer at a young age, or have several relatives with cancer. Contact your cancer care team as soon as possible if you notice a new lump, thickening, unusual discharge or bleeding; a sore that does not heal; a cough or hoarse voice that does not go away; trouble swallowing or a loss of appetite; bone aches; or headaches with vision changes. These symptoms have many causes, but in someone with a cancer history they deserve prompt evaluation rather than waiting for the next scheduled visit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Second Primary Tumors is like, what's helped you, or ask the community a question.